HSBC Holdings’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.9K | Sell |
102,296
-2,691
| -3% | -$1.97K | ﹤0.01% | 2416 |
|
|
2025
Q1 | $85K | Buy |
104,987
+46
| +0% | +$37 | ﹤0.01% | 2387 |
|
|
2024
Q4 | $149K | Buy |
104,941
+3,785
| +4% | +$5.38K | ﹤0.01% | 2377 |
|
|
2024
Q3 | $106K | Sell |
101,156
-2,027
| -2% | -$2.13K | ﹤0.01% | 2402 |
|
|
2024
Q2 | $179K | Buy |
103,183
+9,905
| +11% | +$17.1K | ﹤0.01% | 2240 |
|
|
2024
Q1 | $223K | Sell |
93,278
-6,586
| -7% | -$15.7K | ﹤0.01% | 2218 |
|
|
2023
Q4 | $320K | Buy |
99,864
+16,535
| +20% | +$53K | ﹤0.01% | 1802 |
|
|
2023
Q3 | $313K | Buy |
83,329
+39,669
| +91% | +$149K | ﹤0.01% | 1724 |
|
|
2023
Q2 | $188K | Sell |
43,660
-2,904
| -6% | -$12.5K | ﹤0.01% | 1911 |
|
|
2023
Q1 | $315K | Buy |
46,564
+1,469
| +3% | +$9.95K | ﹤0.01% | 1798 |
|
|
2022
Q4 | $340K | Buy |
45,095
+31,339
| +228% | +$236K | ﹤0.01% | 2023 |
|
|
2022
Q3 | $137K | Sell |
13,756
-35,602
| -72% | -$355K | ﹤0.01% | 2268 |
|
|
2022
Q2 | $363K | Buy |
49,358
+15,205
| +45% | +$112K | ﹤0.01% | 2126 |
|
|
2022
Q1 | $449K | Buy |
+34,153
| New | +$449K | ﹤0.01% | 2147 |
|
|
2021
Q3 | – | Sell |
-10,556
| Closed | -$147K | – | 2518 |
|
|
2021
Q2 | $147K | Buy |
+10,556
| New | +$147K | ﹤0.01% | 2370 |
|
|
2021
Q1 | – | Sell |
-15,446
| Closed | -$269K | – | 2364 |
|
|
2020
Q4 | $269K | Buy |
+15,446
| New | +$269K | ﹤0.01% | 2206 |
|
|
2020
Q3 | – | Sell |
-12,871
| Closed | -$230K | – | 2265 |
|
|
2020
Q2 | $230K | Sell |
12,871
-3,286
| -20% | -$58.7K | ﹤0.01% | 1893 |
|
|
2020
Q1 | $259K | Buy |
16,157
+6,044
| +60% | +$96.9K | ﹤0.01% | 1732 |
|
|
2019
Q4 | $182K | Sell |
10,113
-6,552
| -39% | -$118K | ﹤0.01% | 2296 |
|
|
2019
Q3 | $338K | Buy |
+16,665
| New | +$338K | ﹤0.01% | 1978 |
|